[(1S,3E,5S,9S,11S,15R,19R,23E,24S)-11-tert-butyl-1,15-dihydroxy-19-[(1R)-1-hydroxyethyl]-23-(2-methoxy-2-oxoethylidene)-2,2-dimethyl-17-oxo-6,12,18,25,26-pentaoxatricyclo[19.3.1.15,9]hexacos-3-en-24-yl] octanoate

InChIKey	`BJNQKVADRDIKFO-GTFOYZODSA-N`
Compound Name	[(1S,3E,5S,9S,11S,15R,19R,23E,24S)-11-tert-butyl-1,15-dihydroxy-19-[(1R)-1-hydroxyethyl]-23-(2-methoxy-2-oxoethylidene)-2,2-dimethyl-17-oxo-6,12,18,25,26-pentaoxatricyclo[19.3.1.15,9]hexacos-3-en-24-yl] octanoate
Canonical SMILES	`CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)CCO[C@H](C(C)(C)C)C[C@@H]3CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O3`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	6
Pfam Stratification	Cross-Family
Avg pChEMBL	7.55
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	8.2	pIC50	TTD_MultiTarget
Q05655	PRKCD	Homo sapiens	Human	PF00130 PF21494 PF00069 PF00433	7.6	Ki	ChEMBL;BindingDB
Q04759	PRKCQ	Homo sapiens	Human	PF00130 PF21494 PF00069 PF00433	7.6	Ki	ChEMBL;BindingDB
P05771	PRKCB	Homo sapiens	Human	PF00130 PF00168 PF00069 PF00433	7.4	Ki	ChEMBL;BindingDB
Q02156	PRKCE	Homo sapiens	Human	PF00130 PF00168 PF00069 PF00433	7.3	Ki	ChEMBL;BindingDB
P24723	PRKCH	Homo sapiens	Human	PF00130 PF00168 PF00069 PF00433	7.2	Ki	ChEMBL;BindingDB